KR20180006784A - Cellulose based wound dressing with antimicirobial filler and manufacturing method thereof - Google Patents

Cellulose based wound dressing with antimicirobial filler and manufacturing method thereof Download PDF

Info

Publication number
KR20180006784A
KR20180006784A KR1020160087622A KR20160087622A KR20180006784A KR 20180006784 A KR20180006784 A KR 20180006784A KR 1020160087622 A KR1020160087622 A KR 1020160087622A KR 20160087622 A KR20160087622 A KR 20160087622A KR 20180006784 A KR20180006784 A KR 20180006784A
Authority
KR
South Korea
Prior art keywords
silver
wound dressing
drying
carbon composite
antimicrobial
Prior art date
Application number
KR1020160087622A
Other languages
Korean (ko)
Inventor
박원호
김민희
조동환
권오형
Original Assignee
금오공과대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 금오공과대학교 산학협력단 filed Critical 금오공과대학교 산학협력단
Priority to KR1020160087622A priority Critical patent/KR20180006784A/en
Publication of KR20180006784A publication Critical patent/KR20180006784A/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/46Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0004Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing inorganic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061Use of materials characterised by their function or physical properties
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061Use of materials characterised by their function or physical properties
    • A61L26/008Hydrogels or hydrocolloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0095Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A61L2300/104Silver, e.g. silver sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/108Elemental carbon, e.g. charcoal

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Composite Materials (AREA)
  • Hematology (AREA)
  • Materials For Medical Uses (AREA)

Abstract

The present invention relates to a method for manufacturing a wound dressing by mixing carboxymethyl cellulose with antimicrobial carbon complex without a toxic cross-linking agent and a catalyst for cross-linking and irradiating radiation. Accordingly, a wound dressing, which is harmless to a wound part, is easy to manufacture and shows high degree of cross-linking, absorption and wound healing power, can be manufactured.

Description

항균성 조성물을 함유하는 고기능성 셀룰로오스 창상피복재 및 그 제조방법{Cellulose based wound dressing with antimicirobial filler and manufacturing method thereof}[0001] The present invention relates to a high-functional cellulose wound dressing containing an antimicrobial composition and a method for producing the same,

본 발명은 항균성 조성물을 함유하는 고기능성 셀룰로오스 창상피복재 및 그 제조 방법에 관한 것으로, 보다 상세하게는 분말활성탄을 질산은 용액에 함침하여 열처리한 항균성 탄소복합체를 셀룰로오스 유도체인 카복시메틸셀룰로오스(carboxymethylcellulose, CMC)에 첨가한 후 방사선을 조사하여 가교시켜 수화젤 형태의 창상피복재를 제조하는 방법에 관한 것이다.The present invention relates to a high-functional cellulose wound dressing containing an antimicrobial composition and a method for producing the same, and more particularly to a carboxymethylcellulose (CMC) cellulose derivative, which is obtained by heat-treating a powdery activated carbon impregnated with a silver nitrate solution, And then crosslinking by irradiation with radiation to form a hydrogel-like wound dressing.

일반적으로 생물은 몸(생체)에 결손 부위가 발생할 경우, 그 결손 부위를 어느 정도 스스로 방어하고 자가치유를 하려고 하는 성질을 가지고 있다. 특히, 생체의 결손 부위가 피부일 경우에는 사용되는 피복재의 생체적합성이 엄격히 요구되는 등 상당히 민감한 조건을 만족시켜야 한다. 창상피복재는 창상이나 화상의 치료 보조에 사용되고 있는데, 손상을 입은 피부가 회복될 때까지 일시적으로 환부를 보호하면서 삼출액의 흡수, 출혈 또는 체액 손실 및 감염 방지를 통해 피부의 재생을 돕는 역할을 수행하며 이에 사용되는 재료로는 천연 및 합성 고분자 소재가 사용되고 있다. 피복재의 종류는 제품 형태에 따라 필름형, 폼형, 수화젤형, 하이드로콜로이드형 등으로 분류할 수 있는데, 필름형 피복재는 반투과성 점착제가 부착된 드레싱재로 창상부위를 세균감염으로부터 보호하고 습윤 환경을 유지시켜 상처치유 효과를 유도하며, 다양한 소재의 필름과 점착제를 적용하여 사용되고 있다. 폼형 드레싱재의 경우, 다른 피복재와 비교했을 때, 흡수력과 증발력이 우수하여 삼출액이 많은 깊은 창상에 적합하고 삼출액을 흡수한 후 팽창하며 창상을 압박하여 창상 주위의 부종을 감소시키는 효과가 있다. 수화젤형 피복재는 많은 기공과 미세공간으로 인해 상처에서 배출되는 삼출액의 흡수 능력이 우수하며 산소투과성이 좋기 때문에 피복재뿐만 아니라 혈관이식 및 조직공학용 지지체 등으로 우수한 조직 재생능을 발휘할 수 있다.Generally, a living organism has a property of defending itself to a certain extent and attempting self-healing when a defective site occurs in the body (living body). Particularly, when the defective portion of the living body is skin, the biocompatibility of the cover material to be used is strictly required, and the highly sensitive condition should be satisfied. Wound dressings are used to assist in the treatment of wounds and burns. They help protect the affected area temporarily until the damaged skin is recovered, helping to regenerate the skin through absorption of exudates, bleeding or loss of fluids and infection. Natural and synthetic polymer materials are used as the material to be used. The type of covering material can be classified into film type, foam type, hydration gel type, hydrocolloid type and the like depending on the product form. The film type covering material is a dressing material with a semi-permeable adhesive, which protects the wound area from bacterial infection and maintains a wet environment And it is used by applying film and adhesive of various materials. In the case of foam-type dressing material, it has an excellent absorbing power and evaporation power as compared with other covering materials, so it is suitable for deep wounds having a large amount of effusion, expands after absorbing the effusion, and compresses the wound to reduce swelling around the wound. The hydrated gel-type covering material is excellent in the ability to absorb exudates discharged from wounds due to many pores and micro spaces, and has good oxygen permeability, so that it can exhibit excellent tissue regeneration ability not only for covering materials but also for vascular grafts and tissue engineering supports.

범용 습윤 창상피복재는 폴리우레탄 폼 드레싱재가 주류를 이루고 있으며, 삼출물이 비교적 적은 상처에는 하이드로콜로이드형 피복재가 사용되고 있으나, 피복재의 보험수가는 점점 낮아지는 경향을 보이고 있으므로 보다 고부가가치를 가지는 창상피복재의 개발이 요구되고 있다. 고부가가치의 창상피복재로는 삼출물 흡수를 촉진시키는 드레싱재와 항균작용을 갖는 은 성분을 함유한 감염창상용 드레싱재가 대표적이며 항균성 피복재재의 높은 치료효능이 주목을 받고 있다. 이러한 고기능성 항균성 피복재는 감염창상 치유능에 있어서는 우수한 특성을 보이지만, 판매 가격이 지나치게 고가이며 이에 따라 값싼 원료로부터 값싼 공정을 이용한 항균성을 갖는 고기능성/저가형 치료용 드레싱재의 필요성이 점점 커지고 있는 실정이다.The polyurethane foam dressing material is the mainstream wet wrinkle covering material and the hydrocolloid type covering material is used for the wound having a relatively small amount of exudate. However, since the coverage of the covering material tends to be lowered, development of a wound covering material having a higher added value . As a high value added wound dressing material, a dressing material for promoting the absorption of exudates and a dressing material for infectious wound dressing containing a silver ingredient having an antibacterial action are representative, and the high therapeutic efficacy of the antibacterial dressing material is attracting attention. These highly functional antimicrobial coatings exhibit excellent properties in the wound healing ability of infections, but their selling prices are excessively high, and thus there is a growing need for high-performance / low-cost therapeutic dressings having antimicrobial properties from cheap raw materials through cheap processes.

본 발명의 목적은 상술한 문제점을 해결하기 위하여 방사선 조사에 의한 무독성, 제조용이성을 갖는 창상피복재의 제조 방법을 제공하는 것이다.An object of the present invention is to provide a method for manufacturing a wound dressing material which is non-toxic and easy to manufacture by radiation irradiation in order to solve the above-mentioned problems.

본 발명의 다른 목적은 방사선 조사에 의한 무독성, 제조용이성을 갖는 창상피복재의 제조 방법으로 제조되고 카복시메틸셀룰로오스/항균성 탄소복합체 젤로 구성된 상처치유에 효과적인 창상피복재를 제공하는 것이다.Another object of the present invention is to provide a wound dressing which is manufactured by a method of manufacturing a wound dressing material which is non-toxic and easy to manufacture by irradiation, and which is effective for wound healing composed of carboxymethylcellulose / antibacterial carbon composite gel.

상기와 같은 목적을 달성하기 위하여, 본 발명은To achieve these and other advantages and in accordance with the purpose of the present invention,

(1) 활성탄을 은 전구체염 수용액에 침지하여 활성탄에 은 이온을 흡착하는 단계;(1) a step of immersing activated carbon in an aqueous solution of silver precursor salt to adsorb silver ions on activated carbon;

(2) 상기 단계 (1)의 활성탄을 열처리하여 항균성 탄소복합체를 제조하는 단계;(2) heat treating the activated carbon in the step (1) to produce an antimicrobial carbon composite;

(3) 카복시메틸셀룰로오스(carboxymethylcellulose, CMC)와 증류수를 혼합한 용액에 상기 단계 (2)에서 제조한 항균성 탄소복합체를 첨가하는 단계;(3) adding the antimicrobial carbon composite prepared in step (2) to a mixture of carboxymethylcellulose (CMC) and distilled water;

(4) 상기 단계 (3)의 혼합 용액에 방사선을 조사하여 가교시키는 단계;(4) irradiating and cross-linking the mixed solution of step (3) with radiation;

(5) 상기 단계 (4)에서 제조된 카복시메틸셀룰로오스와 항균성 탄소복합체 젤을 건조하는 단계;를 포함하는 것을 특징으로 하는 무독성이고 제조가 용이하며 상처 치유에 효과적인 창상피복재의 제조방법을 제공한다.(5) drying the carboxymethyl cellulose and the antimicrobial carbon composite gel prepared in the step (4), thereby producing a wound dressing which is non-toxic, easy to manufacture and effective in wound healing.

상기 단계 (1)에서 은 전구체염 수용액은 질산은, 아세트산은, 염화은, 탄산은, 황산은, 브롬화은, 인산은으로 이루어지는 군으로부터 선택되는 하나 이상의 염을 포함하는 수용액이다.In the step (1), the aqueous solution of the silver precursor salt is an aqueous solution containing at least one salt selected from the group consisting of silver nitrate, silver acetate, silver chloride, silver carbonate, silver sulfate, silver bromide and phosphoric acid.

상기 단계 (2)에서 열처리는 불활성 분위기 하에서 250 내지 400℃에서 1분 내지 5시간 이루어진다.In the step (2), the heat treatment is performed at 250 to 400 ° C for 1 minute to 5 hours under an inert atmosphere.

상기 단계 (3)에서 혼합비율은 카복시메틸셀룰로오스 5 내지 20wt%와 증류수를 혼합하고, 이 혼합용액에 항균성 탄소복합체 0.5 내지 3wt%를 첨가한다.In the step (3), 5 to 20 wt% of carboxymethyl cellulose and distilled water are mixed, and 0.5 to 3 wt% of the antibacterial carbon composite is added to the mixed solution.

상기 단계 (4)에서 방사선은 감마선, 전자선, 이온빔, 중성자선, UV 및 플라즈마로 이루어지는 군으로부터 선택되는 어느 하나이고, 방사선 총조사량은 5 내지 100kGy이다.In the step (4), the radiation is any one selected from the group consisting of a gamma ray, an electron beam, an ion beam, a neutron beam, UV, and plasma, and the total irradiation dose is 5 to 100 kGy.

상기 단계 (5)에서 건조는 열 건조, 자연 건조, 및 동결 건조로 이루어지는 군으로부터 선택되는 어느 하나이다.The drying in the step (5) is any one selected from the group consisting of thermal drying, natural drying, and freeze drying.

또한 본 발명은 상기 기재된 방법으로 제조된 항균성 조성물을 함유하는 고기능성 셀룰로오스 창상피복재를 제공한다.The present invention also provides a highly functional cellulose wound dressing comprising an antimicrobial composition prepared by the method described above.

본 발명에 따른 무독성이고 제조가 용이하며 상처 치유에 효과적인 창상피복재는 유독성을 지닌 가교제 및 가교하기 위한 촉매를 사용하지 않고 카복시메틸셀룰로오스와 항균성 탄소복합체를 배합한 후 방사선을 조사하여 창상피복재를 제조하므로 상처 부위에 무해하고, 제조하기 용이하며, 높은 가교도, 고흡수성 및 높은 상처치유력을 나타내므로 창상피복재로 유용하게 사용할 수 있다.The wound dressing material which is non-toxic, easy to manufacture and effective in wound healing according to the present invention is prepared by blending carboxymethyl cellulose and antimicrobial carbon composite without using a crosslinking agent having a toxicity and a catalyst for crosslinking and then irradiating the wound dressing material It is harmless to the wound area, is easy to produce, exhibits high crosslinking degree, high absorbability and high wound healing power, and thus can be usefully used as a wound dressing material.

도 1은 본 발명에 따라 제조된 창상피복재의 단면 사진.
도 2는 본 발명의 실시예 1 내지 실시예 4에 의하여 제조된 창상피복재의 압축강도를 나타낸 그래프.
도 3은 본 발명의 실시예 1 내지 실시예 4에 의하여 제조된 창상피복재의 팽윤도를 나타낸 그래프.
1 is a cross-sectional photograph of a wound dressing prepared according to the present invention.
2 is a graph showing the compressive strengths of the wound dressings prepared according to Examples 1 to 4 of the present invention.
3 is a graph showing the degree of swelling of the wound dressing prepared according to Examples 1 to 4 of the present invention.

이하, 본 발명에 의한 바람직한 실시예를 상세하게 설명한다. 또한, 본 실시예 에서는 본 발명의 권리범위를 한정하는 것은 아니고, 단지 예시로 제시한 것이며, 그 기술적인 요지를 이탈하지 않는 범위 내에서 다양한 변경이 가능하다.Hereinafter, preferred embodiments of the present invention will be described in detail. The present invention is not limited to the scope of the present invention, but is merely an example, and various modifications can be made without departing from the technical spirit of the present invention.

본 발명은 (1) 활성탄을 은 전구체염 수용액에 침지하여 활성탄에 은 이온을 흡착하는 단계; (2) 상기 단계 (1)의 활성탄을 열처리하여 항균성 탄소복합체를 제조하는 단계; (3) 카복시메틸셀룰로오스와 증류수를 혼합한 용액에 상기 단계 (2)에서 제조한 항균성 탄소복합체를 첨가하는 단계; (4) 상기 단계 (3)의 혼합 용액에 방사선을 조사하여 가교시키는 단계; (5) 상기 단계 (4)에서 제조된 카복시메틸셀룰로오스와 항균성 탄소복합체 젤을 건조하는 단계;를 포함하여 이루어진다.(1) a step of immersing activated carbon in an aqueous solution of silver precursor salt to adsorb silver ions on activated carbon; (2) heat treating the activated carbon in the step (1) to produce an antimicrobial carbon composite; (3) adding the antibacterial carbon composite prepared in step (2) to a solution of carboxymethyl cellulose and distilled water; (4) irradiating and cross-linking the mixed solution of step (3) with radiation; (5) drying the carboxymethyl cellulose and the antibacterial carbon composite gel prepared in the step (4).

본 발명의 제조방법에 있어서, 상기 단계 (1)은 활성탄을 은 전구체염 수용액에 침지하여 활성탄에 은 이온을 흡착하는 단계이다.In the production method of the present invention, the step (1) is a step of immersing the activated carbon in an aqueous solution of the silver precursor salt to adsorb silver ions to the activated carbon.

구체적으로, 상기 단계 (1)에서 전구체염 수용액은 질산은, 아세트산은, 염화은, 탄산은, 황산은, 브롬화은, 인산은으로 이루어지는 군으로부터 선택되는 하나 이상의 염을 포함하는 것이 바람직하다. 더욱 구체적으로는 질산은 수용액을 사용하는 것이 더욱 바람직하다.Specifically, in the step (1), the aqueous solution of the precursor salt preferably contains at least one salt selected from the group consisting of silver nitrate, silver acetate, silver chloride, silver carbonate, silver sulfate, silver bromide, and silver phosphate. More specifically, it is more preferable to use an aqueous silver nitrate solution.

본 발명의 제조방법에 있어서, 상기 단계 (2)는 상기 단계 (1)의 활성탄을 열처리하여 항균성 탄소복합체를 제조하는 단계이다.In the production method of the present invention, the step (2) is a step of producing the antimicrobial carbon composite by heat-treating the activated carbon of the step (1).

구체적으로 상기 단계 (2)에서 열처리는 불활성 분위기 하에서 250 내지 400℃에서 1분 내지 5시간 이루어지는 것이 바람직하다. 1분 미만으로 열처리하는 경우 처리 시간이 너무 짧아 음이온 염이 제거되지 않으며, 5시간을 초과하여 열처리하는 경우 항균성 탄소복합체가 너무 산화되어 다음 단계에서 혼합용액에 첨가하기 어려운 물성을 갖게 된다.Specifically, in the step (2), the heat treatment is preferably performed at 250 to 400 ° C for 1 minute to 5 hours under an inert atmosphere. If the heat treatment is performed for less than 1 minute, the treatment time is too short to remove the anion salt, and if the heat treatment is performed for more than 5 hours, the antimicrobial carbon composite is oxidized too much to have a physical property difficult to be added to the mixed solution in the next step.

본 발명의 제조방법에 있어서, 상기 단계 (3)은 카복시메틸셀룰로오스와 증류수를 혼합한 용액에 항균성 탄소복합체를 첨가하는 단계이다.In the production method of the present invention, the step (3) is a step of adding an antimicrobial carbon composite to a solution obtained by mixing carboxymethylcellulose and distilled water.

구체적으로, 상기 단계 (3)에서 혼합비율은 상기 카복시메틸셀룰로오스 5 내지 20wt%와 증류수를 혼합하는 것이 바람직하고, 상기 항균성 탄소복합체 0.5 내지 3wt%를 첨가하는 것이 바람직하다. 5wt% 미만의 카복시메틸셀룰로오스나 0.5wt% 미만의 항균성 탄소복합체는 가교되는 양이 너무 적으며, 20wt%를 초과하는 카복시메틸셀룰로오스나 3wt%를 초과하는 항균성 탄소복합체는 오히려 가교에 방해가 되고, 제조된 창상피복재의 흡수성을 떨어뜨린다.Specifically, in the step (3), 5 to 20 wt% of the carboxymethyl cellulose and distilled water are preferably mixed, and 0.5 to 3 wt% of the antibacterial carbon composite is preferably added. Less than 5 wt% of carboxymethylcellulose or less than 0.5 wt% of the antimicrobial carbon composite is too small to be crosslinked, and more than 20 wt% of carboxymethylcellulose or more than 3 wt% of the antimicrobial carbon composite interferes with crosslinking, The absorbency of the manufactured wound dressing is lowered.

본 발명에 따른 제조방법에 있어서, 상기 단계 (4)는 상기 단계 (3)의 혼합 용액에 방사선을 조사하여 가교시키는 단계이다.In the manufacturing method according to the present invention, the step (4) is a step of irradiating the cross-linking solution of the mixed solution of the step (3).

구체적으로, 상기 단계 (4)에서 방사선은 감마선, 전자선, 이온빔, 중성자선, UV 및 플라즈마로 이루어지는 군으로부터 선택되는 어느 하나인 것이 바람직하고, 감마선, 전자선 및 중성자선으로 이루어진 군으로부터 선택되는 것이 보다 바람직하다.Specifically, in the step (4), the radiation is preferably selected from the group consisting of a gamma ray, an electron beam, an ion beam, a neutron beam, UV and plasma, and is preferably selected from the group consisting of gamma ray, electron ray and neutron ray desirable.

또한 상기 단계 (4)에서 방사선은 총조사량이 5 내지 100kGy인 것이 바람직하다. 방사선의 총조사량이 100kGy를 초과하는 경우 카복시메틸셀룰로오스와 항균성 탄소복합체의 가교에 방해가 되거나, 흡수 후 창상피복재의 물성 및 흡수력을 저하시킬 수 있으므로 바람직하지 않다. 방사선의 조사 시간은 젤화시키고자 하는 카복시메틸셀룰로오스/항균성 탄소복합체의 용액의 양 및 목적하는 젤의 강도 등에 따라 적절히 선택할 수 있다.In the step (4), it is preferable that the total dose of radiation is 5 to 100 kGy. If the total irradiation amount of the radiation exceeds 100 kGy, the crosslinking between the carboxymethyl cellulose and the antibacterial carbon composite may be interrupted, or the physical properties and the absorbing power of the wound dressing after absorption may be lowered. The irradiation time of the radiation can be appropriately selected depending on the amount of the solution of the carboxymethyl cellulose / antibacterial carbon composite to be gelated and the strength of the desired gel.

본 발명에 따른 제조방법에 있어서 상기 단계 (5)는 상기 단계 (4)에서 제조된 카복시메틸셀룰로오스/항균성 탄소복합체 젤을 건조하는 단계이다.In the manufacturing method according to the present invention, the step (5) is a step of drying the carboxymethylcellulose / antibacterial carbon composite gel prepared in the step (4).

구체적으로, 상기 단계 (5)에서 건조는 열 건조, 자연 건조 및 동결 건조로 이루어지는 군으로부터 선택되는 어느 하나인 것이 바람직하나 이에 한정하지 않는다.Specifically, the drying in step (5) is preferably selected from the group consisting of heat drying, natural drying and freeze drying, but is not limited thereto.

또한 본 발명은 상술한 제조방법에 의하여 제조되는 창상피복재를 제공한다.The present invention also provides a wound dressing made by the above-described manufacturing method.

이하에서는 본 발명의 실시예 및 실험예를 통하여 보다 구체적으로 설명한다. 그러나 실시예는 본 발명의 예시에 불과할 뿐, 본 발명의 범위가 이에 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples and Experimental Examples. However, the embodiments are only examples of the present invention, and the scope of the present invention is not limited thereto.

[실시예 1][Example 1]

무게비 1:1로 하여 분말활성탄을 질산은 수용액에 넣고 2시간 교반을 통해 은 이온을 흡착시켰다. 이후 은 이온이 흡착된 분말활성탄을 불활성 아르곤 분위기 하에서 300℃, 1시간 열처리하여 질산이온을 제거하여 항균성 탄소복합체를 제조하였다. 카복시메틸셀룰로오스 15wt%를 증류수와 혼합하고, 항균성 탄소복합체를 1.0wt% 첨가하였다. 다음으로 상기 카복시메틸셀룰로오스/탄소복합체 혼합 용액에 전자선을 회당 10kGy의 선량률로 3회 조사하여 젤화시키고 자연 건조시켜 젤 형태의 카복시메틸셀룰로오스/탄소복합체 창상피복재를 제조하였다.Powdered activated carbon was added to the silver nitrate aqueous solution at a weight ratio of 1: 1, and silver ions were adsorbed by stirring for 2 hours. Thereafter, powdery activated carbon adsorbed on the silver ion was heat - treated at 300 ° C for 1 hour in an inert argon atmosphere to remove nitrate ions to prepare an antimicrobial carbon composite. 15% by weight of carboxymethylcellulose was mixed with distilled water, and 1.0% by weight of an antibacterial carbon composite was added. Next, the carboxymethyl cellulose / carbon composite wound dressing was prepared by irradiating electron beams to the carboxymethyl cellulose / carbon composite mixture solution three times at a dose rate of 10 kGy, gelling and naturally drying.

[실시예 2][Example 2]

상기 전자선을 5회 조사한 것을 제외하고는 실시예 1과 동일하게 창상피복재를 제조하였다.A wound dressing material was prepared in the same manner as in Example 1, except that the electron beam was irradiated five times.

[실시예 3][Example 3]

상기 전자선을 7회 조사한 것을 제외하고는 실시예 1과 동일하게 창상피복재를 제조하였다.A wound dressing material was prepared in the same manner as in Example 1, except that the electron beam was irradiated seven times.

[실시예 4][Example 4]

상기 전자선을 9회 조사한 것을 제외하고는 실시예 1과 동일하게 창상피복재를 제조하였다.A wound dressing material was prepared in the same manner as in Example 1, except that the electron beam was irradiated nine times.

[비교예 1][Comparative Example 1]

상기 탄소복합체 대신 은 이온이 흡착되지 않은 분말활성탄을 첨가한 것을 제외하고는 실시예 1과 동일하게 창상피복재를 제조하였다.A wound dressing material was prepared in the same manner as in Example 1, except that powdered activated carbon in which silver ions were not adsorbed was added instead of the carbon composite material.

[시험예 1][Test Example 1]

상기 실시예에 의하여 제조된 창상피복재가 충분히 젤화되었는지 여부를 확인하기 위하여 SEM을 통해 단면 사진을 촬영하였다. 도 1은 실시예 2에서 제조된 창상피복재를 동결 건조하여 단면 사진을 찍은 것이다. 본 발명에 의하여 제조된 창상피복재가 균일한 기공 구조를 가짐을 알 수 있다.A cross-sectional photograph was taken through an SEM to confirm whether or not the wound dressing prepared according to the above example was sufficiently gelated. FIG. 1 is a cross-sectional photograph of the wound dressing prepared in Example 2 by freeze-drying. It can be seen that the wound dressing prepared according to the present invention has a uniform pore structure.

[시험예 2][Test Example 2]

상기 실시예 1 내지 4를 대상으로 전자선 조사량이 강도에 미치는 영향을 알아보기 위하여 상기 실시예 1 내지 4에 의하여 제조된 창상피복재의 압축강도를 마이크로재료시험기를 이용하여 측정하였고, 그 결과를 도 2에 나타내었다. 전자선의 조사량이 증가함에 따라 압축강도도 증가함을 확인할 수 있었다. 이는 전자선의 조사량이 증가할수록 가교 밀도가 증가하고, 가교 밀도가 증가함에 따라 압축강도도 증가한 것으로 보인다.In order to examine the influence of the electron beam dose on the strength of the above Examples 1 to 4, the compressive strengths of the wound dressings prepared according to Examples 1 to 4 were measured using a micro material tester. Respectively. As the dose of electron beam increases, the compressive strength increases. It is considered that the crosslink density increases with increasing irradiation dose of electron beam, and the compressive strength increases with increasing crosslink density.

[시험예 3][Test Example 3]

상기 실시예 1 내지 4를 대상으로 전자선 조사량이 창상피복재의 팽윤도에 미치는 영향을 알아보기 위하여 상기 실시예 1 내지 4에 의하여 제조된 창상피복재의 팽윤도를 측정하였고, 이의 결과를 도 3에 나타내었다. 전자선의 조사량이 증가함에 따라 팽윤도가 감소함을 확인할 수 있었다. 전자선의 조사량이 증가할수록 창상피복재 내 가교 밀도 증가로 인해 팽윤도가 감소한 것으로 보인다.The swelling degrees of the wound dressings prepared in Examples 1 to 4 were measured in order to examine the effect of the electron beam dose on the swelling degree of the wound dressing in the above Examples 1 to 4. The results are shown in FIG. It was confirmed that the degree of swelling decreased with increasing dose of electron beam. As the irradiation dose of electron beam increases, the degree of swelling decreases due to the increased crosslink density in the wound dressing.

[시험예 4][Test Example 4]

상기 실시예 1 및 비교예 1의 항균성을 시험하였다. ASTM E2149의 방법을 사용하였으며 [표 1]은 그 결과를 나타낸 표이다.The antibacterial properties of Example 1 and Comparative Example 1 were tested. The method of ASTM E2149 was used, and Table 1 shows the results.

실시예 1(탄소복합체)Example 1 (Carbon composite) 비교예 1(분말활성탄)Comparative Example 1 (Powder activated carbon) 항균성
(%)
Antimicrobial activity
(%)
Staphylococcus aureusStaphylococcus aureus Klebsiella pneumoniaeKlebsiella pneumoniae Pseudomonal aeruginosaPseudomonal aeruginosa Staphylococcus aureusStaphylococcus aureus Klebsiella pneumoniaeKlebsiella pneumoniae Pseudomonal aeruginosaPseudomonal aeruginosa
99.999.9 99.999.9 99.999.9 00 99.999.9 99.799.7

Staphylococcus aureus(황색포도상구균)에 대한 항균성 실험에서 실시예 1은 높은 항균성을 나타낸 반면 비교예 1은 항균성을 보이지 않았다.Carried out in the antibacterial test for Staphylococcus aureus (Staphylococcus aureus) Example 1 Comparative Example 1, while showing a high antimicrobial activity did not show antimicrobial activity.

Claims (6)

(1) 활성탄을 은 전구체염 수용액에 침지하여 활성탄에 은 이온을 흡착하는 단계;
(2) 상기 단계 (1)의 활성탄을 열처리하여 항균성 탄소복합체를 제조하는 단계;
(3) 카복시메틸셀룰로오스(carboxymethylcellulose, CMC)와 증류수를 혼합한 용액에 상기 단계 (2)에서 제조한 항균성 탄소복합체를 첨가하는 단계;
(4) 상기 단계 (3)의 혼합 용액에 방사선을 조사하여 가교시키는 단계;
(5) 상기 단계 (4)에서 제조된 카복시메틸셀룰로오스와 항균성 탄소복합체 젤을 건조하는 단계;를 포함하는 것을 특징으로 하는 항균성 조성물을 함유하는 고기능성 셀룰로오스 창상피복재의 제조 방법.
(1) a step of immersing activated carbon in an aqueous solution of silver precursor salt to adsorb silver ions on activated carbon;
(2) heat treating the activated carbon in the step (1) to produce an antimicrobial carbon composite;
(3) adding the antimicrobial carbon composite prepared in step (2) to a mixture of carboxymethylcellulose (CMC) and distilled water;
(4) irradiating and cross-linking the mixed solution of step (3) with radiation;
(5) drying the carboxymethyl cellulose and the antibacterial carbon composite gel prepared in the step (4); and (5) drying the antibacterial carbon composite gel.
제 1항에 있어서,
상기 단계 (1)에서 은 전구체염 수용액은 질산은, 아세트산은, 염화은, 탄산은, 황산은, 브롬화은, 인산은으로 이루어지는 군으로부터 선택되는 하나 이상의 염을 포함하는 수용액인 것을, 상기 단계 (2)에서 열처리는 불활성 분위기 하에서 250 내지 400℃에서 1분 내지 5시간인 것을 특징으로 하는 항균성 조성물을 함유하는 고기능성 셀룰로오스 창상피복재의 제조 방법.
The method according to claim 1,
In the step (1), the aqueous solution of the silver precursor salt is an aqueous solution containing at least one salt selected from the group consisting of silver nitrate, silver acetate, silver chloride, silver carbonate, silver sulfate, silver bromide, Wherein the heat treatment is carried out at 250 to 400 DEG C for 1 minute to 5 hours under an inert atmosphere.
제 1항에 있어서,
상기 단계 (3)에서 카복시메틸셀룰로오스 5 내지 20wt%와 증류수를 혼합하고, 이 혼합용액에 항균성 탄소복합체 0.5 내지 3wt%를 첨가하는 것을 특징으로 하는 항균성 조성물을 함유하는 고기능성 셀룰로오스 창상피복재의 제조 방법.
The method according to claim 1,
Characterized in that in step (3), 5 to 20 wt% of carboxymethyl cellulose is mixed with distilled water, and 0.5 to 3 wt% of an antimicrobial carbon composite is added to the mixed solution. The method for producing a highly functional cellulose wound dressing .
제 1항에 있어서,
상기 단계 (4)에서 방사선은 감마선, 전자선, 이온빔, 중성자선, UV 및 플라즈마로 이루어지는 군으로부터 선택되는 어느 하나인 것을 특징으로 하고, 방사선의 총조사량이 5 내지 100kGy인 것을 특징으로 하는 항균성 조성물을 함유하는 고기능성 셀룰로오스 창상피복재의 제조 방법.
The method according to claim 1,
In the step (4), the radiation is any one selected from the group consisting of a gamma ray, an electron beam, an ion beam, a neutron beam, UV, and plasma, and the total irradiation amount of the radiation is 5 to 100 kGy. ≪ / RTI > by weight of the cellulose.
제 1항에 있어서,
상기 단계 (5)에서 건조는 열 건조, 자연 건조, 및 동결 건조로 이루어지는 군으로부터 선택되는 어느 하나인 것을 특징으로 하는 항균성 조성물을 함유하는 고기능성 셀룰로오스 창상피복재의 제조 방법.
The method according to claim 1,
Wherein the drying in step (5) is any one selected from the group consisting of thermal drying, natural drying, and freeze drying.
제 1항 내지 제 5항 중 어느 한 항에 기재된 방법으로 제조된 항균성 조성물을 함유하는 고기능성 셀룰로오스 창상피복재.
A highly functional cellulose wound dressing comprising an antimicrobial composition produced by the method of any one of claims 1 to 5.
KR1020160087622A 2016-07-11 2016-07-11 Cellulose based wound dressing with antimicirobial filler and manufacturing method thereof KR20180006784A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020160087622A KR20180006784A (en) 2016-07-11 2016-07-11 Cellulose based wound dressing with antimicirobial filler and manufacturing method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020160087622A KR20180006784A (en) 2016-07-11 2016-07-11 Cellulose based wound dressing with antimicirobial filler and manufacturing method thereof

Publications (1)

Publication Number Publication Date
KR20180006784A true KR20180006784A (en) 2018-01-19

Family

ID=61025113

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020160087622A KR20180006784A (en) 2016-07-11 2016-07-11 Cellulose based wound dressing with antimicirobial filler and manufacturing method thereof

Country Status (1)

Country Link
KR (1) KR20180006784A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200013449A (en) * 2018-07-30 2020-02-07 주식회사 원바이오젠 Polyurethane foam dressing comprising silver-activated carbon composites and producing method thereof
KR20230003976A (en) 2021-06-30 2023-01-06 인제대학교 산학협력단 Dressing with increased wound healing speed and manufacturing method thereof
KR20230003977A (en) 2021-06-30 2023-01-06 인제대학교 산학협력단 Dressing with increased wound healing speed and manufacturing method thereof
EP4205770A1 (en) * 2021-12-30 2023-07-05 Paul Hartmann AG In-line beam sterilization for wound coverings

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200013449A (en) * 2018-07-30 2020-02-07 주식회사 원바이오젠 Polyurethane foam dressing comprising silver-activated carbon composites and producing method thereof
KR20230003976A (en) 2021-06-30 2023-01-06 인제대학교 산학협력단 Dressing with increased wound healing speed and manufacturing method thereof
KR20230003977A (en) 2021-06-30 2023-01-06 인제대학교 산학협력단 Dressing with increased wound healing speed and manufacturing method thereof
EP4205770A1 (en) * 2021-12-30 2023-07-05 Paul Hartmann AG In-line beam sterilization for wound coverings
WO2023126293A1 (en) * 2021-12-30 2023-07-06 Paul Hartmann Ag In-line radiation sterilization for wound dressings

Similar Documents

Publication Publication Date Title
KR101377569B1 (en) Antimicrobial Wound Dressing and Preparing Method of the Same
KR20180006784A (en) Cellulose based wound dressing with antimicirobial filler and manufacturing method thereof
JP4984266B2 (en) Method for producing silver-bonded antibacterial wet wound dressing and wet wound dressing produced by the method
KR101865781B1 (en) Hydrogel comprising oxidized polysaccharide and amine-modified hyaluronic acid for wound dressings and manufacturing method thereof
Zhou et al. Acetate chitosan with CaCO3 doping form tough hydrogel for hemostasis and wound healing
JP2974905B2 (en) Swellable wound dressing material
CN105641733A (en) Preparation method for compound antibacterial haemostatic wound dressing
ES2574207T3 (en) Dressing with a layer of biocellulose prepared to adsorb bacteria
CN103751833B (en) Medical antibacterial wound dressing and preparation method thereof
CN114000349B (en) Alginate-encapsulated bacterial cellulose composite photothermal antibacterial medical dressing and preparation method thereof
KR20060134346A (en) Microporous dressing material of chitosan complex and production method
EP2916879B1 (en) Wound care device
RU2519220C1 (en) Local hemostatic agent
Jiang et al. Carboxymethyl chitosan-based multifunctional hydrogels incorporated with photothermal therapy against drug-resistant bacterial wound infection
KR101366417B1 (en) Covering material for antimicrobial moist wound and Method of manufacturing the same
EP4059527B1 (en) Composite collagen sponge for controlled release of active substances, and method of preparation thereof
KR101745635B1 (en) Fiber composite porous structure and process for preparing the same
KR101242579B1 (en) Preparing method of Gel paste for treatment an ulcer including a honey by radiation and Gel paste for treatment an ulcer thereby
KR101208614B1 (en) Preparing method of Gel paste composition for treatment an ulcer including a honey and Gel paste composition for treatment an ulcer thereby
WO2018167622A1 (en) Process for the preparation of wound dressing sponge
KR20180076063A (en) Wound dressing materials based on dextran and manufacturing method thereof
KR101242573B1 (en) Preparing method of Gel for treatment an ulcer including a honey and Gel for treatment an ulcer thereby
CN109706744B (en) Rapid hemostatic and antibacterial hydrocolloid oily yarn and preparation method thereof
Hasan et al. Application of Chitosan in the Medical and Biomedical Field
KR102164484B1 (en) Polyurethane Foam Surface-coated With Chitosan And Method For Manufacturing The Same

Legal Events

Date Code Title Description
A201 Request for examination
N231 Notification of change of applicant
E902 Notification of reason for refusal
AMND Amendment
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
AMND Amendment